Select Page
Responsive Centered YouTube Video
Analysis of COVID-19 booster shots for individuals over 65 and antibody levels post-infection.
  • Discussion on the potential need for a second bivalent booster for individuals over 65 due to a stockpile of updated shots. 0:35

  • Research findings on antibody levels post-normal COVID-19 infection, with most individuals showing 179-800 nanograms per milliliter. 2:02

  • Comparison of antibody levels post-infection versus post-vaccination to determine similar responses. 3:46

Analysis of antibody levels in different age groups raises concerns about the need for Covid boosters.
  • Antibody levels above 800 nanograms per milliliter are prevalent in the population, especially in the 16-24 age group. 4:11

  • Therapeutic ranges are crucial in determining the appropriate dosage of treatments to avoid potential risks. 5:27

  • Over 65% of individuals aged 16-24 have antibody levels exceeding the 800 threshold, indicating potential overexposure to boosters. 7:10

  • Some individuals in the population exhibit antibody levels over 6,000 nanograms per milliliter, significantly higher than the typical range. 7:30

  • The average antibody level is around 300, but a considerable number of individuals, especially younger age groups, have levels well above this threshold. 8:05

High antibody levels post-vaccination raise concerns about infection control effectiveness.
  • Majority of age groups have antibody levels above 800, with some over 6000. 8:13

  • Current Omicron levels surpass those of January 2022, despite high antibody levels. 10:02

  • Over 80s show antibody levels 20 times higher than normal infection rates. 10:43

  • Presence of high antibody levels does not seem to correlate with infection control. 11:02

  • Question raised on the effectiveness of high antibody levels in controlling infections. 11:13